CELEX: 51996PC0563
Language: en
Date: 1996-12-11
Title: Proposal for a COUNCIL REGULATION (EC) providing for duty free treatment for specified pharmaceutical active ingredients bearing an "international nonproprietary name" (INN) from the World Health Organisation and specified products used for the manufacture of finished pharmaceuticals and withdrawing duty free treatment as pharmaceutical products from certain INNs whose predominate use is not pharmaceutical

i   COMMISSION OF THE EUROPEAN COMMUNITIES
                                                   Brussels, 11.12 1996
                                                   COM(96) 563 final
                                                   96/0268 (ACC)
                                    Proposal for a
                          COUNCIL REGULATION (EC)
Providing for duty free treatment for specified pharmaceutical active ingredients bearing
an "international nonproprietary name" (INN) from the World Health Organisation and
specified products used for the manufacture of finished pharmaceuticals and withdrawing
duty free treatment as pharmaceutical products from certain INNs whose predominate use
is not pharmaceutical.
                           (presented by the Commission)
 ---pagebreak---  ---pagebreak---                          EXPLANATORY MEMORANDUM
1. Pursuant to the conclusions reached in Uruguay Round Record of Discussions
   (L/4740 of 25.3.1994) on duty free treatment for pharmaceutical products, the
   Commission has participated in the first review of the product coverage to include, by
   consensus, additional products for duty free treatment.
2. The outcome of the review is that 231 pharmaceutical active ingredients bearing an
   "international nonproprietary name" (INN) from the World Health Organisation and
   234_products used for the manufacture of finished pharmaceuticals should be added to
   the list of products already receiving duty free treatment and also that the list of
   specified prefixes and suffixes for salts and esters of INNs should be expanded by 84
   names.
3. In addition it was concluded that the situation should be rectified in respect of 25
   INNs whose use was predominantly non-pharmaceutical by deleting them from the
   list of INNs receiving duty free treatment.
4. The Commission proposes in line with other countries granting duty free treatment for
   these additional products as early as possible in 1997 that the duty free treatment shall
   commence from 1.1.97.
5. For these reasons the Commission proposes that the Council adopt the Regulation
   contained in the Annex to this communication.
                                           a.
 ---pagebreak---                        PROPOSAL FOR A COUNCIL REGULATION (EC)
Providing for duty free treatment for specified pharmaceutical active ingredients bearing
an "international nonproprietary name" (INN) from the World Health Organisation and
specified products used for the manufacture of finished pharmaceuticals and withdrawing
duty free treatment as pharmaceutical products from certain INNs whose predominant use
is not pharmaceutical
THE COUNCIL OF THE EUROPEAN UNION
Having regard to the Treaty establishing the European Community, and in particular
Article 113 thereof,
Having regard to the proposal from the Commission,
Whereas, in the course of the Uruguay Round negotiations the Community and a number
of countries discussed duty free treatment of pharmaceutical products;
Whereas the participants in those discussions concluded that in addition to products
falling in the Harmonised System (HS) chapter 30 and HS Headings 2936, 2937, 2939
and 2941, duty free treatment should be given to designated pharmaceutical active
ingredients bearing an "international nonproprietary name" (INN) from the World Health
Organisation as well as specified salts, esters and hydrates of such products, and also to
designated products used for the production and manufacture of finished products;
Whereas the results of the discussions, as set out in the Record of Discussions1, were
incorporated into the tariff schedules of the participants annexed to the Marrakesh
Protocol to GATT 1994;
Whereas they also concluded that representatives of the WTO members party to the
Record of discussions would meet under the auspices of the Council for Trade in Goods
of the WTO, normally at least once every three years - to review the product coverage
with a view to including, by consensus, additional pharmaceutical products for tariff
elimination;
Whereas the first such review has taken place with the conclusion that additional INNs
and products used for production and manufacture of finished pharmaceuticals should be
granted duty free treatment and that the list of specified prefixes and suffixes for salts and
esters of INNs should be expanded;
Whereas in the context of the review it was concluded that it was appropriate to rectify
the situation with regard to certain INNs whose use was predominantly non-
pharmaceutical and which had been inadvertently included among those INNs already
 receiving duty free treatment.
 1
   GATT Document L/7430
 ---pagebreak--- HAS ADOPTED THIS REGULATION:
                                            Article 1
From 1 January 1997 the Community shall also accord duty free treatment for the INNs
listed in Annex I as well as the salts, esters and hydrates of such products.
                                            Article 2
From 1 January 1997 the Community shall also accord duty free treatment for the
products used in the production and manufacture of pharmaceutical products listed in
Annex II.
                                            Article 3
From 1 January 1997 the specified prefixes and suffixes of INNs eligible for duty free
treatment shall also include those listed in Annex III.
                                            Article 4
 From 1 January 1997 the products listed in Annex IV together with the salts, esters and
 hydrates of such products shall no longer benefit from duty free treatment.
                                            Article 5
 This Regulation shall enter into force on the day following that of its publication in the
 Official Journal of the European Communities.
 This Regulation shall be binding in its entirety and directly applicable in all Member
 states.
 Done at Brussels,
                                                                For the Council
                                                                The President
                                               \
 ---pagebreak---                                            Annex I
Additional INNs to receive duty free treatment
                                           Annex II
Additional pharmaceutical intermediates, ie compounds used for the manufacture of
finished pharmaceutical products, to receive duty free treatment.
                                           Annex III
Additions to the list of prefixes and suffixes which, in combination with the INNs,
describe salts, esters or hydrates of INNs.
                                           Annex IV
INNs which shall no longer benefit from duty free treatment
 ---pagebreak---                                 FINANCIAL STATEMENT
Section 1.     Financial Implications
1. Proposal for a Council Regulation providing duty free treatment for 465
   pharmaceutical products and withdrawing duty free treatment from 25 products whose
   predominant use is not pharmaceutical.
2. Budget heading: (loss of revenue: not known)
3. Legal basis:         Article 113
4. Description
    The proposal regulation is a consequence of the agreement reached in the Uruguay
    Round to undertake a periodic review of the agreement with a view to including, by
    consensus, additional products for duty free treatment.
5. Type of revenue: Loss of revenue for duties paid on third country imports.
6. Change in level of revenue:
    The withdrawal of duty free treatment from products whose use was predominantly
    non-pharmaceutical with subsequent revenue gains will offset a large proportion of
    the revenue loss for duty free treatment being granted to other products. No figures
    are available for the amounts involved but with this element taken into account the
    duty loss is likely to be less than 2 MECU.
 ---pagebreak---                   Annex I
Additional INNs to receive duty free treatment
                     • \
 ---pagebreak---  CN code        CAS KW    Nam»
2844 40 30  113716-48-6   iolopride (123 I)
            142481-95-6   technetium (99m Tc) furifosmin
2846 90 00  131069-91-5   gadoversetamide
            135326-11-3   gadoxetic acid
            138721-73-0   sprodiamide
2914 40 90   20098-14-0   idramantone
2916 39 00   71109-09-6   vedaprofen
2918 30 00   22161-81-5   dexketoprofen
            112665-43-7   seratrodast
2918 90 90  139403-31-9   pimilprost
2921 49 90  136236-51-6   rasagiline
2922 49 70     6582-31-6  dapabutan
2923 90 00     1794-75-8  laurcetium bromide
2924 10 00     1675-66-7  adelmidrol
              62304-98-7  thymalfasin
            132787-19-0   tradecamide
            129009-83-2   versetamide
2924 29 90  147362-57-0   loviride
              94497-51-5  tamibarotene
2925 19 80  144849-63-8   bisnafide
2925 20 00  137159-92-3   aptiganel
2926 90 80  137109-71-8   balazipone
            147076-36-6   laflunimus
2928 00 90  141579-54-6   fenleuton
2930 90 16    87573-01-1  salnacedin
2930 90 70    90357-06-5  bicalutamide
            112573-72-5   dexecadotril
            107023-41-6   pobilukast
              81110-73-8  racecadotril
2931 00 50  132236-18-1   zifrosilone
2931 00 80  114084-78-5   ibandronic acid
            124351-85-5   incadronic acid
              63132-39-8  olpadronic acid
2932 99 70  105674-77-9   lanproston
2932 99 90  123407-36-3   arteflene
            132017-01-7   bervastatin
            110816-79-0   cromoglicate lisetil
            149494-37-1   ebalzotan
            151581-24-7   iralukast
            113806-05-6   olopatadine
            139110-80-8   zanamivir
2933 29 90  158682-68-9   elisartan
            116684-92-5   galdansetron
              89371-44-8  imidaprilat
            138402-11-6   irbesartan
            118072-93-8   zoledronic acid
2933 39 95  119257-34-0   besipirdine
            118248-91-2    fodipir
            155415-08-0    inogatran
            121750-57-0    itameline
            144412-49-7    lamifiban
             155319-91-8   mangafodipir
             150443-71-3   nicanartine
               29876-14-0  nicotredole
             144035-83-6   piclamilast
             137795-35-8   spiroglumide
             147025-53-4   talsaclidine
             149488-17-5   trovirdine
 2933 40 10  127294-70-6   balofloxacin
             143383-65-7   premafloxacin
             143224-34-4    telinavir
 ---pagebreak--- 2933 40 90    96946-42-8 cisatracurium besilate
2933 40 90  158966-92-8  montelukast
            136668-42-3  quiflapon
2933 59 70  127266-56-2  adatanserin
            106941-25-7  adefovir
            113852-37-2  cidofovir
            150756-35-7  efletirizine
            119687-33-1  iganidipine
            127759-89-1  lobucavir
            140945-32-0  mapinastine
            134208-17-6  mazapertine
             96604-21-6  ocinaplon
            148504-51-2  ripisartan
            115762-17-9  ruzadolane
            118420-47-6  tagorizine
            137234-62-9  voriconazole
            151319-34-5  zaleplon
2933 79 00  148396-36-5  fradafiban
             74436-00-3  geclosporin
            143943-73-1  lirequinil
            106730-54-5  olprinone
            135548-15-1  oxeclosporin
            145733-36-4  tasosartan
            143343-83-3  toborinone
2933 90 95  137882-98-5  abitesartan
            114607-46-4  acitazanolast
            120511-73-1  anastrozole
            134523-00-5  atorvastatin
            128270-60-0  bivalirudin
            139481-59-7  candesartan
              54278-85-2 candocuronium iodide
            105806-65-3  efegatran
              62568-57-4 emideltide
            120081-14-3  goralatide
            142880-36-2  ilomastat
              62732-44-9 ipidacrine
            116287-14-0  lanperisone
            112809-51-5  letrozole
            116644-53-2  mibefradil
            136122-46-8  mipitroban
            144702-17-0  pomisartan
            132036-88-5  ramosetron
            106308-44-5  rufinamide
            144701-48-4  telmisartan
            147059-72-1  trovafloxacin
2934 10 00  149079-51-6  cartasteine
            128312-51-6  cinalukast
              51287-57-1 denotivir
            101001-34-7  pamicogrel
            136433-51-7  tazofelone
            138742-43-5  zankiren
2934 20 90  144665-07-6  lubeluzole
            150915-41-6  perospirone
            146939-27-7  ziprasidone
2934 90 60  130370-60-4  batimastat
            133040-01-4  eprosartan
            135202-79-8  ilonidap
            114686-12-3   imitrodast
            132418-36-1  rocepafant
            132418-35-0   setipafant
 2934 90 70  125533-88-2 mofarotene
             127045-41-4  pazufloxacin
 2934 90 80  118292-40-3  tazarotene
 2934 90 98  151356-08-0  afovirsen
 ---pagebreak---              138298-79-0   alnespirone
             152317-89-0   alniditan
             153420-96-3   atibeprone
             143393-27-5   azalanstat
             149908-53-2   azimilide
             150490-85-0   berupipam
             154361-50-9   capecitabine
             133099-04-4   darifenacin
             137500-42-6   darsidomine
             114030-44-3   dexpemedolac
             115464-77-2   elopiprazole
             141790-23-0   fozivudine tidoxil
             122254-45-9   glenvastatin
             143443-90-7   ifetroban
               82857-82-7  ilepcimide
             104454-71-9   ipenoxazone
             118288-08-7   lafutidine
             138068-37-8   lepirudin
              78994-23-7   levormeloxifene
             116476-16-5   levosemotiadil
             148152-63-0   napitane
               84558-93-0  netivudine
             147432-77-7   ontazolast
             139225-22-2   panâmesine
             103255-66-9   pazinaclone
             123447-62-1   prulifloxacin
             131986-45-3   xanomeline
             145781-32-4   zolasartan
2935 00 90   147536-97-8   bosentan
             136817-59-9   delavirdine
             119905-05-4   delequamine
             112966-96-8   domitroban
             125279-79-0   ersentilide
             139133-26-9   lexipafant
             154397-77-0   napsagatran
             139133-27-0   nupafant
             116649-85-5   ramatroban
             133276-80-9   samixogrel
             146623-69-0   saprisartan
             149556-49-0   susalimod
             144494-65-5   tirofiban
             139308-65-9   tolafentrine
             107753-78-6   zafirlukast
2936 29 90   131875-08-6   lexacalcitol
2937 10 10       9002-68-0 follitropin alfa
             152923-57-4   lutropin alfa
2937 22 00   103466-73-5   icometasone enbutate
2937 29 90   144459-70-1   rofleponide
2937 99 00   124478-60-0   aglepristone
             140703-51-1   examorelin
             133107-64-9   insulin lispro
             144743-92-0   teverelix
 2939 50 90  151581-23-6    apaxifylline
              132210-43-6   cipamfylline
              100324-81-0   lisofylline
                98833-92-2  stacofylline
 2939 90 90   135905-89-4   mirisetron
              117086-68-7   ricasetron
                25775-90-0  zucapsaicin
 2940 00 90   133692-55-4   seprilose
 2941 90 00   127785-64-2   basifungin
  2941 90 00  116853-25-9   cefluprenam
               122841-10-5   cefoselis
               156131-91-8   dimadectin
                                        fa
 ---pagebreak---            123997-26-2 eprinomectin
           149951-16-6 lenapenem
           108852-90-0 nemorubicin
           159445-62-2 orientiparcin
           156769-21-0 sanfetrinem
3001 90 99 120993-53-5 desirudin
3002 10 91 143653-53-6 abciximab
           156227-98-4 afelimomab
           151763-64-3 capromab
           152923-56-3 dacliximab
           145832-33-3 detumomab
           142864-19-5 enlimomab
           152981-31-2 inolimomab
           150631-27-9 nacolomab tafenatox
           159445-64-4 odulimomab
           147191-91-1 priliximab
           153101-26-9 regavirumab
           148189-70-2 votumumab
3002 10 95 143090-92-0 anakinra
           143631-61-2 atexakin alfa
           148637-05-2 cilmostim
           154725-65-2 epoetin epsilon
           148363-16-0 epoetin omega
           102786-52-7 eptacog alfa (activated)
           156679-34-4 lenercept
           124146-64-1 mobenakin
                0-00-0 moroctocog alfa
           148641-02-5 muplestim
           139076-62-3 octocog alfa
3003 39 00      0-00-0 plusonermin
3003 90 90      0-00-0 fuladectin
3507 90 90 143831-71-4 dornase alfa
           154248-97-2 imiglucerase
           149394-67-2 ledismase
           156616-23-8 monteplase
           159445-63-3 nateplase
           155773-57-2 pegorgotein
3911 90 19  95522-45-5 colestilan
            31512-74-0 polixetonium chloride
3913 90 80  39464-87-4 betasizofiran
                0-00-0 certoparin sodium
                0-00-0 minolteparin sodium
                                   11
 ---pagebreak---                                     Annex II
Additional pharmaceutical intermediates, ie compounds used for the manufacture of
         finished pharmaceutical products, to receive duty free treatment.
                                             43.
 ---pagebreak---  est coda       CAS R»     game                                            ^ ^
2843 30 00    12192-57-3   (alpha-D-glucopyranosylthioJgold
2903 69 90    42074-68-0   l-chloro-2-(chlorodiphenylmathyl)benzene
              76283-09-5   alpha,4-dibromo-2-filuorotoluene
2906 29 90   104265-58-9   2-[(is,2R)-6-fluoro-2-hydroxy-1-isoprdpyl-
                           l,2,3,4-tetrahydro-2-naphthyllethyl p-
                           toluenasulfonate
2907   29 90     700-13-0 2, 3,5-triraethylhydjroquinane
2909   50 90  63659-16-5 4- [2-(cyclopropylmethoxy)ethyl]phenol
2914   40 90      80-75-1 ll-alpha-hydroxypregn-4-9ne-3,20-d±ane
2914   50 00    2107-69-9 5,6-diraethoxyindan-l-one
              24916-90-3 9-beta,11-beta-epoxy-l7,2l-dihydroxy-lS-alpha-
                           methylpregna-l,4-diene-3,20-dione
2914 70 90    83881-08-7 21-chloro-9-beta",11-beta-epoxy-17-hydroxy-16-
                           alpha-methylpregna-1,4-diene-3,20-dione
2915 39 90       979-02-2 2Q~oxopregna-5,16-dien-3-beta-yl acetate
2915 90 20       638-41-5 pexityl chloroformate -.       -,
291a 39 00    49708-81-8 trans-4-(p-ahlorophenyl)^yClohexanecarboxylic
                           acid
2917 19 90     48059-97-8 (B) -oct-4-ei»r-l, 8-dloic "acid
               71170-82-6 triethyl 3-bramopropane-l,1,1-tricarboxylate
2917 39   80   27932-00-9 indan-5-yl hydrogen phenylmalonate
2918 13   00    2743-38-6 dibenzoyl-L-tartaric acid
2918 17   00    4358-88-7 ethyl DL-mandel'at*
2918.19   80   563.88-04-6 {(lit, 3R, 5S) ~3 , 5-dlhydroxy-2- [ (E) - (3S) -3-
                            hydroxyoct-l-enyl]cyclopentyl}ac«tic acid
2918 29 90   167678-46-8 3-chloroformyl-o-tolyl acetate
2918 30-00     56105-81-8 (R) -2-(3-benzaylphenyl)propionic acid
               22161-86-0 • {RS)~2-{3-benzoylphenyl)propionic acid
               78834-75-0 ethyl 7-chloro-2-cocoheptanoate
                1944-S3-4 3- [ (3aS,4S,7aS)-7a-methyl-l,S-dioxoactahydro-
                            lH-inden-4-yl]propionic acid
               39562-17-9 methyl 2-(3-nitrobenzylidene)-3-oxobutyrate
 2918 90 90    26159-31-9 (RS)-2-(6-methoxy-2-naphchyl)propionic, acid
             105560-93-8 methyl (2R,3S)-2,3-epoxy-3-(4-
                            methoxyphenyl)propionate
               40098-26-8 methyl 7-[(3RS)-3-hydrpxy-S-oxocyclopent-l-
                            enyl]heptanoate
 2921 19 so     4261-68-1 (2-chloroethyl)diisopropylamine hydrochloride
 2921 59 90      122-75-8 N,N'-dibenzylethylenediammonium di(acetate)
 2922 19 00  126456-43-7 (IS, 2R)-l-aminoindan-2-ol
               68047-07-4 4'-[2-(dimethylamino)ethoxy]-2-
                            phenylbutyrophenone
 2922 30 00      784-38-3 2~araino-5-chloro-2'-fluorob«nzophenone
               156732-13-7 (S)-5-amino-2-(dibenzylamino)-l,6~diphenylhex-
                            4~en73-one
 2922 49 70    37441-29-5 5-amino-2,4,6-triiodoisophthaloyl dichloride
               42854-62-6 ben2yl L-alaninate--p-toluenesulfonic acid
                             (1:1)
               39878-87-0 (-)-alpha- (chloroformyl)benzylammonium
                            chloride
               54527-73-0 2-(N-methylbenzylamino)ethyl 3 -aminobut-2 -
                            enoate
               81677-60-3 methyl (4-nitrophenyl)-L-alaninate
                  949-99-5 3-(4-nitrophenyl)-L-alanine
 2924 10 00   153758-31-7 (2S)-2-aminb-3-hydroxy-N-pentylpropionamide--
                            oxalic acid (1:1)
                                       e
 ---pagebreak---                                                                       ANNEX II
CM code          CAS RM      Name
             13 8531-07-4    L-lysyl-L-leucyl-L-leucyl-L-leucyl-L-leucyl-L-
                             lyayl-L-leucyl-L-leucyl-L-leucyl-L-leucyl-L-
                             lysyl-L-leucyl-L-leucyl-L-leucyl-L-leucyl-L-
                             lysyl-L-leucyl-L-leucyl-L-leucyl-L-leucyl-L-
                             lysine
2924 29 90    4018B-45-2     3'-aoetyl-4'-hydroxybutyranilide
2924 29 90      1149-26-4    N-(banzyloxycarbonyl)-L-valine
             116661-86-0      (2S,3S)-3-(tert-butoxycarbonylamino)-2-
                             bydroxy-4-pheiiylbutyric acid
             144163-85-9     tert-butyl [(is,3S,4S)-4-amiao-l-benzyl-3-
                             hydroxy-5-phenylpentylJcarbamate
             149451-80-9     tert-butyl [(IS,2S)-l-benzyl-2,3-
                             dihydroxypropyl]carbamate
               98737-29-2     tert-butyl {IS)-alpha-[(S)-
                             oxiranyl]phenethyl}carbamate
                     0-00-0   2-chloro-N-[2-(2-chlorob9nzoyl)-4-
                             nitrophenyl]acetamide
             125971-96-2      2- [alpha-(4-fluorobenzoyl)benzyl]-4-methyl-3-
                              oxovaleranilide
               32981-8S-4     methyl (2R,3S)-3-benzamido-2-hydroxy-3-
                              phenylpropionate
292.5 19 80  151860-15-0      meeo-N-benzyl-3-nitrocyclopropane-1,2-
                              dicarboximide
               97338-03-9     «thyl (S)-3-(4-aminophenyl)-2-
                              phthalimidopropionate hydrochloride
               94213-26-0     ethyl (S)-3-{4-[bis(2-
                              chloroethyl)amino]phenyl} -2-
                              phthalimidopropionate hydrochloride
2926 90 80     58311-73-2      (Z)-(2-cyanovinyl)trimethylammonium p-
                              toluenesulfonate
              133481-10-4     ethyl (1-cyanocyclohexyl)acetate
              123632-23-5     4-(2,2,3,3 -tetrafluoropropoxy)cinnamon!trile
 2328 00 90    94213-23-7      (Z)-[cyano(2,3-
                              dichlorophenyl)methylene]carbazamidine
 2930 90 16   159453-24-4     N-(benzyloxycarbanyl)-S-phenyl-L-cysteine
 2930 90 70   159878-02-1     benzyl (1R,2S)-3-chloro-2-hydroxy-l-
                               (phenylthiomethyl)propylcarbamate
              136511-43-8      ethyl N-{2-[(acetylthio)methyl]-3-(o-tolyl)-1-
                              oxopropyl}-L-methionate
 2932 19 00     97148-39-5     ammonium (Z)-2-methoxyimino-2-(2-furyl)acetate
 2932 29 80        517-23-7    alpha-acetyl-gamma-butyrolactone
                 6559-91-7     4'-demethylepipodophyllotoxin
                3 9521-49-8     (3aR,4bS,4R,4aS,5aS)-4-(5,5-dimethyl-1,3-
                               dioxolan-2-
                               yl)hexahydrocyclopropa[3,4]cyclopenta[1,2-
                               b]furan-2(3H)-one
                39746-Q1-5      (3aR, 4R, 5R, 6aS) -4-formyl-2-oxohaxahydro-2H-
                               cyclopenta[b]furan-5-yl benzoate
                   976-70-5    3-oxopregn-4-ene-21,17-alpha-carbolactone
  2932 99 50    32981-86-5     ia-deacetylbaccatin III
  2932 99 70      7512-17-6    2-acetamido-2-deoxy-beta-D-glucopyranose
                79944-37-9     trans-6-amino-2.2-dimethyl-1,3-dioxepan-5-ol
               125971-94-0      tert-butyl [(4R,6R)-6-(cyanomethyl)-2,2-
                                dimethyl-i,3-dioxolan-4-yl]acetate
                   467-55-0     3-beta-hydroxy-5 -alpha-epiro3tan-12-one
                    533-31-3    3,4-(methylenedioxy)phenol
                                          4t
 ---pagebreak---                                                                   ANNEX II
 CM code        CAS RM    Nana
2933 11 90     6150-97-6  magnesium bis[(2,3-dihydro-l, 5-dimethyl-3-oxo-
                          2-phenyl-IH-pyrazol-4 -
                          yl)methylamino]methanesulfonate
2933 19 90   27511-79-1 3-aminopyrazole-4-carbaxamide hemisulfate
2933 29 90     4897-25-0 5~chloro-l-methyl-4-nitroimidazale
2933 39 95  142057-79-2 (RS)-2-[(l-benzyl-4-piperidyl)methyl]-5,6-
                          dimethoxyindan-l-one
            120014-07-5 2-[(l-benzyl-4-piperidyl)methylene]-5,6-
                          dimethoxyindan-1-one
               6 935-27-9 benzyl(2-pyridyl)amine
              87848-95-1 6-bromo-2-pyridyl p-tolyl ketone
              32998-95-1 N-(tert-butyl)-3-methylpyridina-2-carboxamide
2933 39 95    84449-80-9 1-[2-(4-carboxyphenoxy)ethyl]piperidinium
                          chloride
              83949-32-0 4-carboxy-4-phenylpiperidinium p-
                           coluenesulfonate
              38092-89-6 8-chloro-6,ll-dihydro-11-(l-methyl-4-
                          piperidylidene)-SH-benzo[5,6]cyclohepta[l,2-
                          b]pyridine
              31255-57-9 3-[2-(3-chlorophenyl)ethyl]pyridine-2-
                           carbonitrile
            107256-31-5 3-[2-(3-chlorophenyl)ethyl]-2-pyridyl 1-
                           methyl-4-piperidyl ketone hydrochloride
                6298-19-7 2-chloro-3-pyridylamine
                5424-11-3 2,2-diphenyl-4-piperidinovaleronitrile
            108555-2S-5 1-[2-(4-methoxyphenyl)ethyl]-4-piperidylamine
                           dihydrochloride
                4046-24-6 5-(l-methyl-4-piperidyl)-5H-
                           dibenzo[a,d]cyclohepten-5-ol hydrochloride
            139886-0^-7 1-methyl-l,2,5,6-t«trahydropyridine-3-'
                           carbaldehyde (E)-O-methyloxime hydrochloride
              70708-28-0 1-(2-pyridyl)-3-(pyrrolidin-1-yl)-1-(p-
                           tolyl)propan-l-ol
                1619-34-7 quinuclidin-3-ol
 2933 40 10 1059S6-96-5 7-[3-{tert-butoxycarbonylamino)pyrrolidin-1-
                           yl]-8-chloro-l-cyclopropyl-6-fluoro-4-oxo-l,4-
                           dihydroguinoline-3-carboxylic acid
              86393-33-1 7-chloro-1-cyclopropy1-6-f1uoro-4 -oxo-1,4-
                           dihydroquinoline-3-carboxylic acid
            H2811-72-0 l-cyclopropyl-6,7-difluoro-B-methoxy-4-oxo-
                           1,4-dihydroquinoline-3-carboxylic acid
              98349-25-8 ethyl 1-cyclopropyl-6,7-difluoro-4-oxo-l,4-
                           dihydroquinoline- 3 -carboxylate
 2933 40 90  159878-04-3 benzyl (IS,2B)-3- [ (3S,4aS,8aS)-3-tert-
                           butylcarbamoylperhydro-2-isoguinolyl]-2-
                           hydroxy-1-(phenylthiomethyl)propylcarbamate
             15 9989-64-7 (3S,4aS,8aS)-N-(tert-butyl)-2-[(2S,3S}-2-
                           hydroxy-3- (3-hydraxy-2~methylbe.nzamido) -4-
                            (phenylthio)butyl]perhydroisoquinaline-3-
                           carboxarnide
             15 998 9-65-8 (3S,4aS,8aS)-N-(tert-butyl)-2-[(2S,3S)-2-
                           hydroxy-3-(3-hydroxy-2-methylbenzamido)-4-
                            (phenylthio)butyl]perhydroisoquinoline-3-
                            carboxamide--methane8Ulfonic acid (1:1)
             120578-03-2 3-'[ (E) - 2 - (7 -chloro-2-
                            quinolyl)vinyl]benzaldehyde
                                      15
 ---pagebreak---                                                                    ANNEX II
CM code         CAS RM    H*»«
               1087-69-0  (9S,13S,14S)-3-methoxymorphinan hydrochloride
             64228-78-0   pent ante thyl ene bis{3-[i-(3,4-dimethoxybenzyl)-
                          6,7-dimathoxy-i,2,3,4-tetrahydro-2-
                          isoquinolyl]propionate}--oxalic acid (1:2)
2933 59 70   75128-73-3 2-[(2-acetamido-6-0x0-6,9-dihydro-lH-purin-9-
                          yDmethoxy] ethyl acetate
               3056-33-5 N- (9-acetyl-6-oxo-6,9-dihydro-lH-purin-2-
                          yl)acetamide
             10310-21-1 2-amino-6-chloropurine
            124832-31-1 2-[(2-amino-6-oxo-l,6-dihydro-9H-purin-9-
                          yl)methoxy]ethyl N-(benzyloxycarboayl)-L-
                          valinate
            150378-17-9 (2R,4S)-2-benzyl-5-[2-(tert-butylcarbamoyl)-4-
                           (3-pyridylmethyl)piperaz in-1-yl]- 4 -hydroxy-N-
                           [ (1S.2R)-2-hydroxyindan-l-yl]valeramida
2933 59 70 157810-81-6 (2R,4S)-2-benzyl-5-[2-(tert-butylcarbamoyl)-4-
                           (3-pyridylmethyl)piperazin-l-yl]-4-hydroxy-N-
                           [(IS,2R)-2-hydroxyindan-1-yl]valeramide
                          sulfate
            150323-35-6 (3S)-1-(tert-butoxycarbonyl)-3-(tert-
                          butyl carbamoyl)pipera z ine
              41202-32-8 <l-(2-chlorophenyl)piperazine hydrochloride
              13078-15-4 1-(3-chlorophenyl)piperazine hydrochloride
                  71-30-7 cytoaine
            149062-75-9 1,3-dlchlorO-6,7,8,9,10, 12-
                          hexahydroazepino[2,l-b]quinazoline
                          hydrochloride
             ,41202-77-1 1-(2, 3-dichlorophenyl)piperazine hydrochloride
              56177-80-1 2-ethoxy-5-fluorapyrimidin-4(1H)-one
            112733-45-6 ethyl (7-chloro-2,4-dioxo-l, 2 , 3 , 4-
                           tetrahydroquinazolin-1-yl)acetate
              59703-00-3 4-ethyl-2,3-dioxopiperazine-l-carbonyl
                           chloride
              64090-19-3 1-(4-fluorophenyl)piperazine dihydrochloride
            147539-21-7 i3opropyl[2-(piperazin-1-yl)-3-pyridyl]amine
              35386-24-4 1-(2-methoxyphenyl)piperazine
                5464-78-8 1-(2-methoxyphenyl)piperazine hydrochloride
             145012-50-6 (7RS,9aRS)-perhydropyrido[l,2-a]pyrazin-7-
                           ylmethanol
                2210-93-7 1-phenylpiperaziniura chloride
             111641-17-9 4-(piperazin-1-yl)-2,6-bia(pyrrolidin-I-
                           yl)pyrimxdine
                  68-94-0 purin-6(1H)-one
               70849-60-4 1-(o-tolyl)piperazine hydrochloride
 2933 69 80    58909-39-0 tetrahydro-2-methyl-3-thioxo-l,2,4-criazine-
                            5.6-dione
 2933 79 00 135297-22-2 (3S,4R)-3-[(R)-1-(tert-
                           butyldimethylsilyloxy)ethyl]-4-[(lR,3S)-3-
                           methoxy-2-oxocyclohexyl]azetidin-2-one
             141646-08-4 l-{[(cyclohexyloxy)carbonyl]oxy}ethyl l-(l-
                            hydroxyethyl)- 5-methoxy-2-oxo-
                            1,2,5,6,7,8,8a,8b-octahydroazeto[2,1-
                            a]isoindale-4-carboxylate
              132127-34-5 (3R,4S)-3-hydroxy-4-phenylazetidin-2-one
                75363-99-4 p-nitrobenzyl (2R.5R,6S)-6-[(R)-l-
                            hydroxyethyl]-3,7-dioxo-l-
 ---pagebreak---                                                                    ANNEX II
CM code        CAS RM
                         azabicyclo[3 .2 . o] hop tane-2-car boxy late
           141316-45-2   potassium l-(1-hydroxyethyl)-5-raethoxy-2-oxo-
                         1,2,5,6,7,8,8a,8b-octahydroazeto[2,1-
                         a]isoindole-4-carboxylate
2933 90 60   59467-64-0  [7-chloro-5-(2-fluorophenyl)-2,3-dihydro-lH-
                         1,4-benzodiazepin-2-yl]methylamine
             59469-29-3  [7-chloro-5-(2-fluorophenyl)-2,3-dihydro-lH-
                         l,4-benzodiazepin-2-ylmethyl]ammonium
                         bis(maleate)
             59467-69-5  8-chloro-6-(2-fluorophenyl)-l-methyl-3a,4-
                         dihydro-3H-imidazo[l', 5-a] [1, 4] benzodiazepine
             5946 9-63-5  7-chloro-5-(2-fluorophenyl)-3-methyl-2-
                          (nitromethylene)-2,3-dihydro-lH-l,4-
                         benzodiazepine 4-oxide
             59467-63-9  7-chloro-5-(2-fluorophenyl)-2-
                          (nitromethylene)-2,3-dihydro-lH-l, 4-
                         benzodiazapine
2933 90 95 130404-91-0   N-[(R)-2-({(R)-2-[(2-
                         adamantyloxycarbonyl)amino]-3-(lH-indol-3-yl)-
                          2-methyl-1-oxopropyl}amino) -1 -
                         phenylethyl]succinamic acid--i-deoxy-l-
                         methylamino-D-glucitol (1:1)
           122536-48-5    3-[(S)-3-(L-alanylamino)pyrrolidin-i-yl]-i-
                          cyclopropyl-6-fluoro-4-oxo-l, 4-dihydro-l,8-
                         naphthyridine-3-carboxylic acid hydrochloride
           122536-91-8    7-{(S)-3-[(S)-2-(tert-butoxycarbonylamino)-l-
                          oxopropylamino]pyrrolidin-1-yl}-l-cyclopropyl-
                          6-fluoro-4-oxo-l,4-dihydro-l,8-naphthyridine-
                          3-carboxylic acid
            134575-17-0   tert-butyl meso-3-azabicyclo[3.1.0]hex-6-
                          ylcarbamate
            122536-66-7   tert-butyl { (S) -l-methyl-2-oxo-2- [ (S) -1
                          pyrrolidin-3-ylamino]ethyl}carbamate
            140629-77-2   tert-butyl [(RS)-pyrrolidin-3-yl]carbamate
            100361-18-0   7-chloro-l-cyclopropyl-6-fluoro-4-oxo-l,4-
                          dihydro-1,8-naphthyridine-3-carhoxylic acid
             38150-27-5   S-chloro-2-[3-(hydroxymethyl)-5-methyl-4H-
                          1,2,4-triazol-4-yl]benzophenone
              36916-19-5  5-chloro-2- (3r-methyl-4H-l, 2 ,4-triazol-4-
                          yl )benzophenone
              54196-62-2  2' , 5-dichloro-2- [3- (hydroxymethyl) -5-mathyl-
                          4H-1,2,4-triazol-4-yl]benzophenone
              54196-61-1  2',5-dichloro-2-(3-methyl-4H-1,2,4-triazol-4-
                          yl)benzophenone
            141113-28-2    (E)-(+)-2-(2,4-difluorophenyl)-l-{3-[4-
                           (2,2,3,3-tecrafluoropropoxy)styryl]-1H-1,2,4-
                          triazol-i~yl}-3-(1H-1,2,4-triazol-l-yl)propan •
                          2-ol
            141113-41-9    (R)-2-(2,4-difluorophenyl)-3-(1H-1, 2,4-
                          triazol-l-yl)propane-l,2-diol
            144034-80-0   dimethyl{2-[5-(1H-1,2,4-triazol-1-
                          ylmethyl)indol-3-yl]ethyl)amine
            122665-86-5    ethyl [3-(cyanomechyl)-4-oxo-3, 4-
                           dihydrophthalazin-l-yl]acetate
              41340-36-7   2-(7-ethyl-iH-indol-3-yl)'ethanol
              95885-13-5   5-ethyl-4- (2-phenoxyethyl)-4H-1, 2 . 4»triazol-
                                     ^
 ---pagebreak---                                                                            ANNEX II
 CM coda           CAS RN    Name
                             3 (2H) -one
                96107-94-7   ethyl 1H-tetrazole-5-carboxylate, sodium salt
                96034-57-0   trans-4-hydroxy-i-(4-nitrobenzyloxycarbonyl)-
                             L-proline
               160194-26-3   2-iodo-4-(1H-1,2.4-triazol-l-ylmethyl)aniline
                66635-71-0   isopropyl 2,3-dihydro-lH-pyrrolizine-l-
                             carboxylate
                  4928-88-5  methyl 1H-1,2,4-triazole-3-carboxylate
                      0-00-0 1,4,7,10-tetraazacyclododecane-i,4,7-triacetic
                             acid sulfate
               112193-77-8   1,4,7,10-tetraazoniacyclododecane bis(sulfate)
                  3641-08-5  lH-l,2,4-triazole-3-carboxaroide
—•          —;    4928-87-4  1H-1,2.4-triazole-3-carboxylic acid
                  6969-71-7  l,2,4-triazolo[4,3-a]pyridin-3(2H)-one
 2934 10 00    171485-87-3   2-[4-(2-amino-4-oxo-4,5-dihydrothiazol-5-
                             ylmethyl)phénoxymethyl]-2,5,7,8-
                             tetramethylchroman-6-yl acetate
                 65872-41-5   (Z)-2-(2-aminothiazol-4-yl)-2-
                             methoxyiminoacetic acid
                 64486-18-6   (2)-2-[2-(chloroacetamido)thiazol-4-yl]-2-
                              (mechoxyimino)acetic acid
                 76823-93-3   1-{4-[(2-cyanoethyl)thiomethyl]thiazol-2-
                             yl}guanidine
2934 10 00     139340-56-0    (S-[(Z)-3,S-di(tert-butyl)-4-
                             hydroxybenzylidene]-4-oxo-4,5-dihydrothiazol-
                              2-yl}ammonium methanesulfonate
                 64485-88-7   ethyl (Z)-2-(2-aminothiazol-4-yl)-2 -
                              (methoxyimino)acetate
                 66339-00-2   ethyl 2-(hydroxyimino)-2-[2-
                              (tritylamino)thiazol-4-yl]acetate
                              hydrochloride
                 88046-01-9   2-guanidinothiazol-4-ylmethyl
                              carbamimidothioate dihydrochloride
               154212-61-0    N-[2-isopropylthiazol-4-
                              ylmethyl(methyl)carbamoyl]-L-valine
                 66215-71-2    (Z)-2-methoxyimino-2-[2-(tritylamino)thiazol-
                              4-yl]acetic acid
                154212-59-6   4-nitrophenyl thiazol-5-ylmethyi carbonate
                              hydrochloride
                 38585-74-9   thiazol-5-ylmethanol
                155213-67-5   thiazol-5-ylmethyl (IS,2S,4S)-l-benzyl-2-
                              hydroxy-4-{(2S)-2-[3-(2-iaopropylthia2ol-4-
                              ylmethyl) -3-methylureido] -3-methylbuty*;avnido} -
                              5-phenylpentylcarbamate
 2934 20 50       80756-85-0  S- (benzothiazol-2-yl) (Z)-2- (2-aminotbi-(sol-4-
                              yl)-2-methoxyiminothioacetate
 2934 20 90       87691-88-1   1-(I,2-bensisothiazdl-3-yl)piperazine
                               hydrochloride
  2934. 30 50   111974-69-7    2-(2-[4-(dibenzo [b, f ] [l, 4) thiazepin-i:5-
                               yl) piperazin-1-yl] ethaxy}atha.nol
                  42399-49-5    (3S, 3S) - 3 - hydroxy - 2 - (4-methoxyphenyl) •". ^
                               dihydro-l,5-benzothiazepin-4(5H)-on®
  2934 90 60    115787-67-2    2 » (2-amino-5-nltro-6-oxo-l, 6-dihydropyr : ' ixdi.n-
                               4-yl) -3- (3-thienyl)propionon.itrile
                 117829-20-6   2~amino~7-thenyl-i,7-dihydro-4H-pyrraXoD ( 3~
                               d]pyrimidin-4.-one hydrochloride
                                           1
 ---pagebreak---                                                                    ANNEX n
CM coda        CAS RM     Nam*
           112887-68-0    N-{5-[(1,4-dihydro-2-mcthyl-4-oxoquinazolin-6-
                          ylmethyl)methylamino]-2-thenoyl}-L-glutamic
                          acid
           161005-84-1     (S)-N,N-dimethyl-[3-(2-thienyl)-3-(l-
                          naphthyloxy)propyl]amine--phosphoric acid
                           (1:1)
           104795-66-6    3-isopropoxy-5-methoxy-N-(lH-tetrazol-5-
                          yl)benzo[b]thiophene-2-carboxamide
           104795-67-7    3-isopropoxy-5-methoxy-N-(lH-tetrazol-5-
                          yl)benzo[b]thiophene-2-carboxamide--lH-
                           imidazole (1:1)
           104795-68-8    3-iaopropoxy-5-methoxy-N-(lH-tetrazol-5-
                          yl)benzo[b]thiophene-2-carboxamide. sodium
                           salt
             63675-74-1    6-methoxy-2-(4-methoxyphenyl)benzo[b]thiophene
           138564-59-7     5-methyl-2-(2-nitroanilino)thiophene-3-
                           carbonitrile
2934 90 70   25229-97-4    2-cyano-3-morpholinoacrylamide
2934 90 80 119221-49-7     5-[(2-aminoethyl)amino]-2-(2-
                           diethylaminoethyl)-2H-
                            (l]benzothiopyrano[4,3,2-cd]indazol-8-ol
           147086-81-5      (43.6S)-5,6-dihydro-6-methyl-4H-thieno[2,3 -
                           b]thiopyran-4-ol 7,7-dioxide
2934 90 98       58-61-7   adenosine
            152305-23-2     (S)-4-(4-aminobenzyl)oxazolidin-2-one
              71420-85-4   7-amino-3-[1-(aulforaethyl)-lH-tetrazol-5-
                           ylthiomethyl]-3-cepham-4-carboxylic acid,
                           sodium salt
              29706-84-1   3•' -azido-3 ' -deoxy-5 ' -O-tritylthymidine
2934 90 98    51762-51-7   benzhydryl 3-hydroxy-7-
                            (phenylacetamido)cepham-4-carboxylate
            110314-42-6    5-[(benzofuran-2-ylcarbonyl)amino]indole-2-
                           carboxylic acid
            131986-28-2    3- (4-chloro-l,2, 5-thiadiazol-3-yl)pyridine
            107452-89-1    omega-conotoxin M VIIA
            126429-09-2    2-(dichloromethyl)-4,5-dihydro-5-(4-
                           meaylphenyl)oxazol-4-ylmethanol
            126813-11-4     (4R,5R)-2-(dichloromethyl)-4.5-dihydro-5-(4-
                           mesylphenyl)oxazol-4-ylmethanol
               4097-22-7   2',3'-dideoxyadenosine
            139264-17-8     (S)-4-{[3-(2-dimethylaminoethyl)-lH-indol-5-
                           yl]methyl}oxazolidin-2-one
            110351-94-5     (S) -4-ethyl-4,-hydroxy-7,8-dihydro-lH-
                           pyrano[3,4-f]indolizine-3,6,10(4H)-trione
            140841-32-3     6- [3-fluora-5-(4-methoxytetrahydropyran-4-
                            yl)phenoxymethyl]-l-methyl-2-quinolone
              94732-98-6    1-(l-{3-[2-(4-fluorophenyl)-1,3-dioxolan-2-
                            yl]propyl}-4-piperidyl)-2,3-dihydro-lH-
                            benzimidazole-2-thione
             125935-03-1     (4R,6R)-G-{2- [2-(4-fluorophenyl)-5-isopropyl-
                            3-phenyl-4-(phenylcarbamoyl)pyrrol-1 -
                            yl]ethyl}-4-hydroxytetrahydro-2H-pyran-2-one
             131988,-19-7   3- (4-hexyloxy-l,2. S-thiadiazol-3-yl! -1-
                            methylpyridinium iodide
             147027-10-9     (1R,2S,5R)-menthyl (2R,5S)-5-(4-amino-2-oxo-
                             l, 2-dihydropyrimidin-l-yl)-1,3-oxathiolane-2-
 ---pagebreak---                                                                   ANNEX II
CM c o d e     CAS RM     Mane
                          carboxylate
            147126-62-3   (1R,2S,5R)-menthyl (2R,5R)-5-hydroxy-1,3-
                          oxathiolane-2-carboxylate
            104218-44-2   3'-0-mesyl-5'-O-tritylthymidine
             27255-72-7   3-methyl-7-(phenylacetamido)-3-cephem-4-
                          carboxylic acid
                  0-00-0  (1R,2S,3S,6R)-[(S)-l-phenylethyl]-3.6-
                          epoxyt et rahydrophtha1imide
             32231-06-4   1-piperonylpiperaziiMS
             55612-11-8   5 *-O-tritylthymidine
2935 00 90  151140-66-8    (4-amino-3-iodophenyl)-N-
                          methylmethanesulfonamide
            112101-81-2   5-[(R)-(2-aminopropyl)]-2-
                          methoxybenzeneaulfonamide
            120298-38-6   N-(5,6-dihydro-6-methyl-2-sulfamoyl-4H~
                          thieno[2,3-b]thiopyran-4-yl)acetamide 7,7-
                          dioxide
            1S0975-9S-4   5-methanesulfonamidoindole-2-carboxy1ic acid
             84522-34-9   sodium 4-[2-(5-methylpyrazine-2-
                          carboxamido)ethyl]benzenesulfonamide
2939 10 00   66820-84-6    (RS)-tetrahydropapaverine hydrochloride
2940 00 90   13035-61-5   1,2.3,5-tetraacetyl-beta-D-ribofuranose
3824 90 64      330-95-0  1,3-bis(4-nitrophenyl)urea- -4,6-
                          dimathylpyrimidin-2-ol (1:1)
            104832-01-1    (R)-6,7-dimethoxy-2-methyl-1-(3,4,5-
                          trimethoxybenzyl)-1,2, 3,4-
                          tetrahydroisoquinoline--dibenzoyl-L-tartaric
                          acid (1:1)
                  0-00-0  Intermediate concentrate obtained from a
                          genetically-modified Escherichia coli
                          fermentation medium, containing human
                          granulocyte-macrophage colony-stimulating
                           factor,- for use in the manufacture of
                          medicaments of HS Mo. 3002
3824 90 64        0-00-0   Intermediate concentrate obtained from a
                          genetically-modified Escherichia coli
                           fermentation medium, containing human
                           interferon alpha-2b; for use in the
                          manufacture of medicaments of HS No. 3002
                   0-00-0  Intermediate concentrates obtained from a
                           Micromonospora inyoensis fermentation medium
                           used for the manufacture of the antibiotics
                           sisomiein (INN) and netilmicin (INN)
                   0-00-0  Intermediate concentrates obtained from a
                           Micromonospora purpurea fermentation medium
                           used for the manufacture of the antibiotics
                           gentaraicin sulfate (ÏNNM) and isepamicin (INN)
 3824 90 95        0-00-0  ethyl 7-chloro-2-oxoheptanoate, in the form of
                           a solution in toluene
 3911 90     162430-94-6    1,6-hexanediamine, polymer with 1,10-
                            dibromodecane
 3913 90 80   83513-48-8    danaparoid sodium
                                      c2o
 ---pagebreak---                                        Annex III
Additions to the list of prefixes and suffixes which, in combination with the INNs,
                      describe salts, esters or hydrates of INNs.
                                               51
 ---pagebreak---  ACETURATE
 N-ACETYLGLYCINATE
 ACISTRATE
 ACOXIL
 AMSONATE
 BENZATHINE
 BEZOMIL
 BUCICLATE
 BUNAPSILATE
 BUTEPRATE
BUTYL ESTER
CARBESILATE
p-CHLOROBENZENESULFONATE
p-CHLOROBENZENESULPHONATE
CICLOTATE
CIPIONATE
CLOSILATE
CLOS YL ATE
CROBEFATE
CROMACATE
CROMESILATE
CYCLOPENTANEPROPIONATE
CYCLOTATE
CYPIONATE
DAPROPATE
DEANIL
DECIL
DIBUDINATE
DIBUNATE
DIETHANOLAMINE
DIGOLIL
N,N-DIMETHYL-beta-ALANINE
DIOLAMINE
DOCOSEL
DOFOSFATE
EDAMINE
EDISYLATE
EPOLAMINE
ERBUMINE
ETABONATE
ETHANOLAMINE
ETHYLENEDIAMINE
FARNESIL
FENDIZOATE
FOSTEDATE
HIBENZATE
HYBENZATE
HYCLATE
o-(4-HYDROXYBENZOYL)BENZOATE
ISOCAPROATE
LAURIL
LAURILSULFATE
LAURILSULPHATE
LAURYL
LAURYLSULFATE
LAURYLSULPHATE
MEGALLATE
METEMBONATE
4-METHYLBICYCLO[2.2.2]OCT-2-ENE-l-CARBOXYLATE
MOFETIL
 OCTIL
 OLAMINE
 OXOGLURATE
 PENDETIDE
                                              n
 ---pagebreak--- PIVOXETIL
PROXETIL
1 -PYRROLIDINEETHANOL
SODIUM LAURIL SULFATE
SODIUM LAURIL SULPHATE
SODIUM LAURYL SULFATE
SODIUM LAURYL SULPHATE
STEAGLATE
TENOATE
TEPROSILATE
TETRADECYL HYDROGEN PHOSPHATE
TOFESILATE
TRICLOFENATE
TRIETHANOLAMINE
TRIFLUTATE
TROLAMINE
TROMETAMOL
TROMETHAMINE
TROXUNDATE
XINAFOATE
                              %
 ---pagebreak---                                      Annex IV
             INNs which shall no longer benefit from duty free treatment
 CN code      CAS RN       Name
2903 22 00     79-01-6     trichloroethylene
2903 30 10    811-97-2     norflurane
2903 51 10     58-89-9     lindane
2906 21 00    100-51-6     benzyl alcohol
2915 29 00 82279-57-0      zinc acetate, basic
2922 41 00     56-87-1     lysine
2922 42 90     56-86-0     glutamic acid
2922 49 10     56-40-6     glycine
2922 50 00     72-19-5     threonine
2923 10 10     67-48-1     choline chloride
2928 00 90     79-17-4     pimagedine
2930 90 20    111-48-8     thiodiglycol
2933 90 95     73-22-3     tryptophan
3102 70 10    156-62-7     calcium carbimide
3904 61 10  9002-84-0      politef
3906 90 90 54182-57-9      carbomer
3907 20         0-00-0     macrogol ester
3907 20 12 25322-68-3      macrogol
3907 20 21 25301-02-4      tyloxapol
3907 60 10 25038-59-9      pegoterate
3908 10 00 25038-54-4      policapram
3910 00 00  9006-65-9      dimeticone
3912 20 11  9004-70-0      pyroxylin
3912 31 00  9000-11-7      carmellose
3912 39 80  8063-82-9      hypromellose
                                            l\
 ---pagebreak---                                                                  ISSN 0254-1475
                                                          COM(96) 563 final
                                             DOCUMENTS
EN                                                             02 05 09      15
                                    Catalogue number : CB-C0-96-562-EN-C
                                                             ISBN 92-78-10884-7
Office for Official Publications of the European Communities
L-2985 Luxembourg
                                                 25